News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Vectura Group plc To Develop New Inhaler With Germany’s Boehringer Ingelheim Corporation; Vectura To Receive Initial Payment Of 5 Million Euro
April 19, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Vectura Group PLC said it has signed a deal with German pharmaceutical company Boehringer Ingelheim to develop a dry powder inhaler for asthma and chronic obstructive pulmonary disease (COPD).
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
Boehringer Ingelheim
MORE ON THIS TOPIC
Manufacturing
Violations at Novo’s Indiana Plant ‘Unacceptable,’ FDA Says
October 14, 2025
·
2 min read
·
Tristan Manalac
Artificial intelligence
Takeda Makes $1B+ AI Bet With Nabla to Build Out Early Pipeline
October 14, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Novo Retreats From Cell Therapy, Axes Hundreds as Restructuring Rolls On
October 13, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH EVOTEC
Strategic Drug Development in a Funding Crisis: Expert Insights on Risk Profiling, Efficiency, and Innovation
October 13, 2025
·
8 min read
·
BioSpace Insights
